Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CD5 is a transmembrane glycoprotein and a member of the scavenger receptor superfamily. It is predominantly expressed on T cells and a subset of B cells and functions as a key regulator of immune responses. CD5 primarily acts by modulating signaling through the T cell receptor (TCR) and B cell receptor (BCR), generally inhibiting their activation. It's involved in thymocyte selection, peripheral tolerance, and differentiation of T helper cell subsets. As such, it represents a potential therapeutic target for immune-related diseases.
Modulation of T cell receptor (TCR) and B cell receptor (BCR) signaling pathways, primarily through negative regulation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD5 protein (CD5).